Current Challenges & Opportunities in Clinical Research Compliance.

Slides:

Advertisements

Similar presentations

Susan Burner Bankowski, M.S., J.D. Chair, OHSU IRB

Advertisements

USC Clinical Trials Office (CTO) Answers to CTOs who, what, when, and how questions Soheil Jadali Director, Clinical Trial Office.

Central IRBs An IRB Infoshort June Working Definition  A central IRB is one that serves as IRB of record for all of the sites engaged in a research.

USC Clinical Trials Office (CTO) Submitting your Studies to CTO For Processing Soheil Jadali Director, Clinical Trial Office.

Module 1 About University Research Responsibilities of PI and Research Staff Research at the University of Michigan PI and Research Staff Responsibilities.

VISN 20 Multi-Site IRB. VISN 20 Institutional Review Board Who we are: VISN 20 includes the states of Alaska, Washington, Oregon, most of the state of.

Research Study Initiation Process GRU CLINICAL AND TRANSLATIONAL RESEARCH LABORATORY RESEARCH ANIMAL RESEARCH HUMAN RESEARCH GRU Clinical.

Clarity, consent and coverage for research-related injuries 6 th Annual Columbia University IRB Conference Boston, MA Patrick Taylor Children’s Hospital.

Multi-Institutional Facilitated IRB Review Philip A. Cola, MA Vice President, Research and Technology University Hospitals Case Medical Center Third Annual.

ANPRM Single IRB Review mandated for multi-site domestic research P. Pearl O’Rourke, M.D. Partners Health Care.

YALE MASTER SLIDE HERE Clinical Research Management – Is not just a handshake deal? Jamie Caldwell, MBA Director Office of Research Services for the Health.

National Cancer Institute (NCI) Central Institutional Review Board (CIRB) Research Studies UCSF HRPP Submission Process Overview Tuesday, December.

Reality vs Urban Myth: The Truth About Regulations

Overview of Good Clinical Practices (GCPs)

Legal Aspects of Clinical Trials Shekhar Potkar Director Clinical Research Pfizer Limited.

Are IRBs Efficient, Effective, or Redundant? David C. Clark, Ph.D. Director, Research Compliance Rush University Center.

Responsible Conduct of Research (RCR) Farida Lada October 16, 2013

Overview Whirlwind overview of Harvard Catalyst

Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.

Pre-Award Issues Related to Human Research and Animal Use March 15, 2013.

WHO IS WATCHING? WHAT ARE THEY WATCHING? WHY SHOULD I CARE? WHAT SHOULD I DO?

Office of Clinical Research and Innovative Care Compliance (OCRICC) What You Need To Know About Conducting Research at Froedtert Hospital Roberta Navarro,

University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.

RESEARCH PROGRAM UPDATE Sarah Castro, MPH Senior Research Support Liaison.

Gynecologic Oncology Group Gynecologic Oncology Group (GOG) Sharon Stockman, C-CRC The University of Iowa Hospitals Iowa City, IA Chair, GOG Data Management.

UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.

Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.

Rebecca Nickleson, MS, CRA Assistant Director Office of Research & Sponsored Programs.

Office of Research & Development (ORD) Local Accountability of Research 2009 Baltimore, Maryland January 13-14, 2009 “Meeting the Current Challenges of.

Research Compliance: Models for Managing - Panel Carol Blum, Council on Governmental Relations (COGR) Peter Dunn, Purdue University Ara Tahmassian, Boston.

LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.

Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.

Business Operations Pre-Award. What is required to begin the business process? Possible indicators CDA executed Cancer Center MDG/PRC approvals Department.

Research Orientation to SCCA. What is the SCCA? The SCCA brings together the outstanding adult and pediatric oncology patient care services of three world-

APPROVAL CRITERIA AN IRB INFOSHORT MAY CFR CRITERIA FOR IRB APPROVAL OF RESEARCH In order for an IRB to approve a research study, all.

Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.

Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.

The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.

The TJU Human Research Protection Program (HRPP) Part II, Conflict of Interest and IRB Noncompliance J. Bruce Smith, MD, CIP.

Office of Research & Development (ORD) Local Accountability of Research 2009 Baltimore, Maryland January 13-14, 2009 “Meeting the Current Challenges of.

VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs.

VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.

1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.

Using A Central IRB At Thomas Jefferson University / Hospital Roseann Talarico Associate Director Office of Human Research.

PRIMER: Human Subjects, Past, Present, and Future Susan Metosky, Arizona State University Debra Murphy, Arizona State University.

Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.

THE INSTITUTIONAL REVIEW BOARD. WHAT IS AN IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.

Institutional Review Board (IRB) 101 Oleg Kisselev, Administrative IRB Chair *This presentation was prepared/presented.

Business Operations Pre-Award. Confidential Disclosure Agreements (CDA)/ Non-Disclosure Agreements (NDA)

Department of Defense (DoD) Funded Human Subjects Research J. Bruce Smith, MD.

Research at Prospects & Research Internal Funding Partnerships Ethics & Compliance Graduate Programs Publicity & Promotion Intellectual Property Accounting.

DMC Research Compliance Our mission is to assure that all research at the DMC is ethical, safe and compliant with regulatory standards; and to support.

IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.

GCP (GOOD CLINICAL PRACTISE)

RESEARCH OVERSIGHT AT TULANE UNIVERSITY BRIAN J. WEIMER, JD TULANE UNIVERSITY RESEARCH COMPLIANCE OFFICER February 23, 2015.

Research Billing Compliance University of Iowa Health Care

Research with Children’s Healthcare of Atlanta

Research Compliance and Institutional Review Boards

Introduction to the Human Research Protections Office (HRPO)

Patricia M. Alt, Ph.D. Dept. of Health Science Towson University

Overview: IRBshare  IRBchoice

Introduction to Clinical Trials: Documents and Processes

Brown Bag Series First Tuesday of each month (except July)

HUMAN RESEARCH PROTECTION PROGRAM or

To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.

AAHRPP + IRB Update Michael Mahoney

To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.

Director, Risk and Compliance

Research Billing Compliance University of Iowa Health Care

Event Reporting in Human Subjects Research

Presentation transcript:

Current Challenges & Opportunities in Clinical Research Compliance

Current Challenges and Opportunities in Clinical Research Compliance Gayle Kusch, Sr. Director, Compliance, Research Integrity Office, Wayne State University & Director, Michigan Neonatal Biobank Monica Malian, System Executive Director, Clinical and Translational Research, Detroit Medical Center Ginette Borovicka, Manager, Research Integrity, Research Integrity Office, Wayne State University

Current Challenges and Opportunities in Clinical Research Compliance This session will be a panel exploring various perspectives of how monitoring activities are conducted throughout a Human Research Protection Program (HRPP). Discussion topics include: how various components of a HRPP work together to monitor research compliance of clinical studies, challenges & opportunities for collaborative monitoring. Monitoring triggers; for-cause audits versus established/scheduled monitoring. This discussion will also explore internal monitoring and review committees, data safety monitoring boards and plans, etc. Audience participation will be encouraged for sharing ideas and experiences.

Human Research Protection Program (HRPP) General Components Upper Administration Legal Counsel Sponsored Programs Technology Commercialization Investigators Research Staff IRB Members IRB Staff Compliance/Integrity Office Department Deans/Chairs Contractual Entities Other Review Committees Institutional Biosafety Radiation Safety Scientific Review Financial Conflict Interest DID I MISS ANY (I am sure I did)

Challenges & Opportunities for Collaborative Monitoring Before the Clinical Research Begins Legal Counsel/Sponsored Programs/Technology Commercialization Research Related Injuries Does the Clinical Trial Agreement Match the Informed Consent How does your Institution handle this? Material Transfer Agreements Other Review Committees Institutional Biosafety, Radiation Safety, Scientific Review, Financial Conflict of Interest Do other Contracted Entities have other reviews that need to happen (Billing Compliance) What other reviews/process does your Institution have?

Challenges & Opportunities for Collaborative Monitoring After the Clinical Research Begins Monitoring – Scheduled…Not For Cause WSU Experience Karmanos Cancer Institute – Audits 12 Investigator Initiated studies per year If problems found report sent to IRB VAMC – Research Compliance Officer conducts a consent audit on all open protocols once per year Report sent IRB Detroit Medical Center - Tenet, Inc (DMC parent co.) audits all open protocols at one of the DMC hospitals per year. If problem found PI instructed to complete a Unexpected Problem report, and Sr. Director, Compliance notified Opportunities to share experiences

Challenges & Opportunities for Collaborative Monitoring After the Clinical Research Begins Monitoring For Cause Triggers – WSU experience Lapses in IRB approval Unexpected Problem Reports Sponsor Audits Problems on Renewal form Problems with an Amendment Local Data Safety & Monitoring Boards Opportunities to share experiences